Just going to leave this here: antimicrobialstewardship.com/paxlovid-ddi-o… Jason Bergsbaken, PharmD, MBA, BCOP Benyam Muluneh, PharmD, BCOP, FHOPA Richa Shah Robert Mancini, PharmD, BCOP, FHOPA Ryan Haumschild PharmD, MS, MBA, CPEL Mimi Lo Jasmine Patel Morgan Homan, PharmD, BCOP Zahra M, PharmD, MBA, BCOP, FHOPA Eugene Przespolewski PharmD BCOP🏴‍☠️ LeAnne Kennedy #LLwL Erin Hickey Zacholski, PharmD, BCOP Britny Brown Amir Ali, PharmD, BCOP James Davis, PharmD, BCOP

Did you participate in the 2021 #oncopharm survey? we’re baaack!! Planning a summit to address how to improve work for oncology pharmacists in hospitals/clinics. If you have ever worked in these roles, participate in part 2! Consider it holiday homework! unc.az1.qualtrics.com/jfe/form/SV_5h….

Any oncology pharmacists at Dana-Farber here that wouldn’t mind shooting me a DM? Have some questions about Clinical Pathways. #oncopharm #oncology #pharmacy

Priyamvadha Sundar You and your mentor are very kind. Credit for thalidomide in myeloma goes to Dr. Barlogie. I confirmed his findings later and led the phase III trial that led to approval. But without Dr. Barlogie there will be no thalidomide. I honored him in this video. youtu.be/sDcN4ethsKk

My rules for myself on #MedTwitter -Remember patients are on Twitter -Live up to the standards of your profession -Be kind -No personal attacks -Assume positive intent -Don’t be rude -Don’t engage with people who are rude -Respond to colleagues & patients with questions

Paradigm Changes in Myeloma. #MedTwitter 1. End organ damage is no longer needed to diagnose myeloma. The Lancet Oncology linkinghub.elsevier.com/retrieve/pii/S…

So great to see all the fabulous match news today! If you’re a PGY1 looking for a phenomenal PGY2 amb care program in a progressive and supportive environment, UNC Med Center Pharmacy Residency Programs is seeking candidate in the Phase 2 match! Share, Reach out or check us out!

Our comprehensive review on dietary and microbiome evidence in plasma cell disorders Richa Parikh AlexanderLesokhin MD Francesca Castro and Matteo Bellone MSK Department of Medicine Leukemia Journal #mmsm #microbiome #nutrition #diet rdcu.be/c8JFV

Proud to share that I’ve 👩‍🎓 from 8 months of training to become an IntlCoachingFederation Certified Professional Coach (CPC). Excited to use this skill set to help others succeed! Coaching can help anyone looking to develop and grow. Stay tuned for plans to offer coaching services!

Out of pocket spending on expensive medicines will come crashing down for patients on Medicare part D next year. #MedTwitter In myeloma, instead of paying $13,000 out of pocket a year on Revlimid, Medicare Part D recipients will pay max of around $3300 next year. KFF

🚨🚨Headline results of SWOG S1826 showing that Nivolumab-AVD has better PFS than brentuximab vedotin-AVD in the upfront treatment of Hodgkin lymphoma, with less toxicity, a 🧵👇🏻 #ASCO23 #lymsm

Grateful to have been involved with this important study. Excellent work by Chris Jensen and team! #mmsm #ASCO2023

The serum free light chain FLC assay. Tutorial. #MedTwitter #MyelomaVR Frequently ordered and frequently abnormal. This thread will reduce unnecessary headaches and referrals. 1/ Don’t order it unless you are suspecting myeloma, amyloid or related disorder

Calling all cards pharmers! The Univ. of North Carolina Medical Center (Chapel Hill) is recruiting for a Heart Failure and Cardiac Surgery inpatient pharmacist. The posting is at jobs.unchealthcare.org/jobs/13286253-…. Please reach out to me if you'd like to discuss/hear more! ACCP Cardiology PRN

Pivotal research on Revlimid wasn't funded by Celgene, but by NIH & tax-advantaged donations. Then Celgene blocked generic competition costing patients & our health system billions. We must pass the bipartisan bills in Congress to curb this type of abuse. sciencedirect.com/science/articl…

This was a long time coming, fantastic collab between Manni Mohyuddin Zahra M, PharmD, MBA, BCOP, FHOPA David Mitchell and Daniel G. Aaron, MD, JD “The story of the development of generic lenalidomide: How one company thwarted the Waxman-Hatch Act to generate billions of dollars in revenue” pubmed.ncbi.nlm.nih.gov/37777010/

Thousands of workers at Walgreens and CVS are launching a 3-day walkout today. Across the country, pharmacists and technicians are protesting low pay, inconsistent hours, and an unmanageable workload. Upwards of 5,000 workers are striking and protesting at CVS and Walgreens HQ.

HOPARX members: cast your votes by 12/2 for board elections! Consider supporting Kamakshi Rao who has been a leading voice in calling for transformative changes for our profession!

For those trying to decide between traditional Medicare and Medicare Advantage — please read this article. Mayo Clinic Proceedings Hagop Kantarjian,MD Amer Zeidan MBBS,MHS ‏عامر زيدان #MedTwitter cc: Andy Slavitt 🇺🇦 @policydeb Link: mayoclinicproceedings.org/pb-assets/Heal…